This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n12http://linked.opendata.cz/resource/drugbank/drug/DB03000/identifier/pdb/
n2http://linked.opendata.cz/resource/drugbank/drug/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03000/identifier/pubchem-compound/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03000/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03000/identifier/drugbank/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03000
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB03000 n8:DB03000
dcterms:title
9-Hydroxypropyladenine, S-Isomer
adms:identifier
n10:DB03000 n11:46508593 n12:APS n13:445211
n3:IUPAC-Name
n4:271B45D9-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B45DF-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B45DE-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B45DB-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B45DC-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B45DD-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B45D7-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B45D8-363D-11E5-9242-09173F13E4C5 n4:271B45D5-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B45D6-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B45E5-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B45E6-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B45E0-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B45E1-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B45E3-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B45E2-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B45E4-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B45EB-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B45ED-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B45EE-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B45EA-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B45E9-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B45EC-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B45DA-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B45E7-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B45E8-363D-11E5-9242-09173F13E4C5